Nashat Amir

Insider Buys Quantity –
4
2021-05-21SaleMorphic Holding, Inc.
MORF
director
232,295
0.6421%
$45.50$10.57M+11.87%
2019-08-01SaleFate Therapeutics, Inc.
FATE
director
61,732
0.0973%
$22.53$1.39M+8.83%
2019-07-31SaleFate Therapeutics, Inc.
FATE
director
62,278
0.0951%
$22.53$1.4M+5.03%
2019-07-30SaleFate Therapeutics, Inc.
FATE
director
180,350
0.2697%
$22.51$4.06M+2.13%
2019-07-29SaleFate Therapeutics, Inc.
FATE
director
658
0.001%
$22.50$14,805+3.43%
2019-07-26SaleFate Therapeutics, Inc.
FATE
director
55,658
0.0832%
$22.50$1.25M-0.53%
2019-07-24SaleFate Therapeutics, Inc.
FATE
director
39,732
0.0605%
$22.51$894,197+1.27%
2019-07-23SaleFate Therapeutics, Inc.
FATE
director
124,066
0.1854%
$22.50$2.79M-0.98%
2019-07-22SaleFate Therapeutics, Inc.
FATE
director
97,408
0.1458%
$22.52$2.19M-0.89%
2019-07-19SaleFate Therapeutics, Inc.
FATE
director
2,106
0.0033%
$22.50$47,385+3.93%
2019-07-18SaleFate Therapeutics, Inc.
FATE
director
42,818
0.064%
$22.50$963,589-1.31%
2019-07-01PurchaseMorphic Holding, Inc.
MORF
director
250,000
0.5381%
$15.00$3.75M-24.54%
2019-01-30SaleFate Therapeutics, Inc.
FATE
director
106,034
0.1567%
$14.16$1.5M+19.07%
2019-01-29SaleFate Therapeutics, Inc.
FATE
director
195,000
0.2962%
$14.16$2.76M+22.32%
2019-01-28SaleFate Therapeutics, Inc.
FATE
director
140,000
0.2154%
$13.78$1.93M+26.99%
2019-01-25SaleFate Therapeutics, Inc.
FATE
director
180,000
0.2706%
$14.14$2.55M+20.7%
2019-01-18SaleFate Therapeutics, Inc.
FATE
director
78,966
0.1235%
$16.28$1.29M+8.04%
2018-12-20SaleFate Therapeutics, Inc.
FATE
director
66,948
0.1172%
$12.25$820,321+35.06%
2018-12-19SaleFate Therapeutics, Inc.
FATE
director
182,420
0.3337%
$13.40$2.45M+28.91%
2018-12-13SaleFate Therapeutics, Inc.
FATE
director
35,576
0.0658%
$16.67$593,127+4.3%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us